Crossmark

Assessing the efficacy and safety profiles of 0.025% tretinoin in treating axillary hyperpigmentation with acanthosis nigricans: a randomized double-blinded study

Crossref DOI link: https://doi.org/10.1007/s00403-025-03821-y

Published Online: 2025-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chunekamrai, Puri

Chatpimolkul, Nattasit

Thummawatwimon, Soravit

Treesirichod, Arucha https://orcid.org/0000-0001-8299-988X
Funding

Funding for this research was provided by:

Srinakharinwirot University (005/2567)
License Information

Text and Data Mining valid from 2025-01-20

Version of Record valid from 2025-01-20
More Information

Article History

Received: 14 October 2024

Revised: 31 December 2024

Accepted: 3 January 2025

First Online: 20 January 2025

Declarations

:

: The study has been approved by the Institutional Review Board and Ethics Committee of Srinakharinwirot University.

: All patients have provided written informed consent.

: Written informed consent has been provided by all patients before enrolment.

: SWUEC 360/2565F.

: NCT06213987.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below